BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11647258)

  • 1. Gene enhancements' thorny ethical traits.
    Weiss R
    Washington Post; 1997 Oct; ():A1, A18-19. PubMed ID: 11647258
    [No Abstract]   [Full Text] [Related]  

  • 2. Human gene therapy: application, ethics and regulation.
    Baskerville G
    Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
    [No Abstract]   [Full Text] [Related]  

  • 3. Human gene therapy research: technological temptations and social control.
    Baram M; Proctor S; Andalman R; van Eyl D
    Genetic Resour; 1993; 7(2):10-5. PubMed ID: 11656942
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene treatments for human illness may be tried soon.
    Angier N
    N Y Times Web; 1990 Aug; ():A1, A12. PubMed ID: 11646772
    [No Abstract]   [Full Text] [Related]  

  • 6. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 7. Girl, 4, becomes first human to receive engineered genes.
    Angier N
    N Y Times Web; 1990 Sep; ():1, 9. PubMed ID: 11646774
    [No Abstract]   [Full Text] [Related]  

  • 8. Public of 2 minds on genetic shifts.
    Schneider K
    N Y Times Web; 1987 May; ():21. PubMed ID: 11646570
    [No Abstract]   [Full Text] [Related]  

  • 9. The challenge of biotechnology.
    Gore A; Owens S
    Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468
    [No Abstract]   [Full Text] [Related]  

  • 10. Federal embryo research is backed: ethicists see benefits overriding qualms.
    Weiss R
    Washington Post; 1999 May; ():A1, A16. PubMed ID: 11648116
    [No Abstract]   [Full Text] [Related]  

  • 11. The first kids with new genes.
    Thompson L
    Time; 1993 Jun; 141(23):50-3. PubMed ID: 11652148
    [No Abstract]   [Full Text] [Related]  

  • 12. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
    Lehrman S
    Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
    [No Abstract]   [Full Text] [Related]  

  • 13. F.D.A. stand on cloning raises even more questions.
    Stolberg SG
    N Y Times Web; 1998 Jan; ():A14. PubMed ID: 11647307
    [No Abstract]   [Full Text] [Related]  

  • 14. Public regulation of recombinant dna gene therapy.
    McGarity TO; Shapiro SA
    J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676
    [No Abstract]   [Full Text] [Related]  

  • 15. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 16. Fighting for Jacob.
    Winerup M
    N Y Times Mag; 1998 Dec; ():56-63, 78, 80,. PubMed ID: 11647624
    [No Abstract]   [Full Text] [Related]  

  • 17. For first time, gene therapy is tested on cancer patients.
    Angier N
    N Y Times Web; 1991 Jan; ():A1, A18. PubMed ID: 11646836
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene dream fades away.
    Coghlan A
    New Sci; 1995 Nov; 148(2005):14-5. PubMed ID: 11656474
    [No Abstract]   [Full Text] [Related]  

  • 19. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 20. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.